25 results on '"Oguike M"'
Search Results
2. Effects of Diluents on Cock Spermatozoa Motility, Viability, Fertility and Hatchability
- Author
-
Ezike, J. C., Jombo, B. I., Ezea, J., Nathaniel, J., Anigbogu, N. M., and Oguike, M. A.
- Subjects
fluids and secretions ,Semen, Diluents, Motility, Viability, Fertility and Hatchability - Abstract
The study evaluated the effects of coconut water + egg yolk (CW- EY), egg yolk citrate (EYC) and skimmed milk (SM) diluents on spermatozoa motility, viability, egg fertility and hatchability in chicken. A total of 84 mature birds (48 hens and 36 cocks) randomly distributed to 4 treatments (T1 –T4) were used. T1 was raw semen, while T2 –T4 were diluted with coconut water + egg yolk, egg yolk citrate, and skimmed milk respectively. The birds were fed a 16.5 CP and 2.60 energy layers’ diet. The cocks were evaluated for the basic semen quality indices prior to the experiment. Raw semen samples were then diluted with each diluent and subjected to microscopic examination for individual progressive motility and viability every 10 minutes for 60 minutes. Semen samples were pooled from 3 cocks in each treatment and diluted in the ratio of 1:3. Aliquots - 0.1ml raw semen (T1) and 0.25ml diluted semen (T2 = T4) were drawn and deposited into the reproductive tract of the hen. 240 eggs were incubated and candled. The result showed significant (P < 0.05) effects of diluents on spermatozoa individual motility. T2 and T3 were statistically not significant (P > 0.05), and were comparable with T1. T4 had the least (70.75) PSM value at 20 – 60min post dilution. Percentage fertility (PF) was significantly (P < 0.05) affected by diluent. T1 and T2 had higher (95.37 and 94.80) PF than T3 and T4. The number of infertile eggs (NI) was significantly (P < 0.05) affected by diluent. T3 and T4 had higher (14.33 and 18.33) NI than T1 and T2. The number of dead embryos was not affected by diluent (P >0.05). Percentage hatchability (PH) was significantly (P < 0.05) affected by diluent. T2 had the highest PH (97.59) than T3 (94.49) and T4 (90.24).T1 had the least (98. 89) PH result. The result indicated significant (P < 0.05) effect of diluent on the percentage viable spermatozoa (PV). PV was higher in T1 (99.00 and 98.00) than T2 (97.75 and 96.50) and T3 (97.50 and 95.25) and lowest in T4 (77.75). T2 and T3 compared favorably with T1 and least (77.75) in T4 from 20 – 60minutes post dilution.
- Published
- 2022
3. Histological Changes and Internal Organs Dynamics of Broiler Chickens Administered Jatropha tanjorensis Leaf Meal.
- Author
-
Amaduruonye, W., Charles, P. C., Agida, C. A., Macartan, B. P., Nathaniel, J., Ezea, J., and Oguike, M. A.
- Subjects
BROILER chickens ,POULTRY ,HISTOPATHOLOGY ,HISTOLOGY ,PHAGOCYTES ,IMMUNE system - Abstract
This study was conducted to examine the effect of Jatropha tanjorensis leaf meal as a natural feed supplement on the internal organs and histology of the kidney and liver of broiler chickens. One hundred and thirty-two (132) unsexed broiler chicks were randomly divided into 4 different groups (T1, T2, T3 and T4) of 33 birds, with 3 replicates of 11 birds per replicate. The experimental diets were formulated to contain 0%, 1.5%, 3.0% and 3.5% dietary supplementation of Jatropha tanjorensis leaf meal, respectively. The internal organs dynamics were determined. The kidney and liver were processed for histopathological examination. Results showed that Jatropha tanjorensis leaf meal at 1.5%, 3.0% and 3.50% in broiler diets significantly (p<0.05) increased the weights of the large intestine (T1 0.49 - T3 0.67), small intestine (T1 1.43 - T3 2.93), kidney (T1 0.42 - T4 0.61) and reduced the crop (T1 0.61 - T2 0.51). The supplementation of Jatropha tanjorensis leaf meal at 1.5%, 3.0% and 3.5% had multifocal hepatocellular necrosis with marked infiltration of the phagocytes of the histoarchitecture of the liver; while the supplementation up to 3.0% and 3.5% on the broiler diets showed a mild multifocal tubular necrosis with marked aggregation of phagocytes on the histo-architecture of the kidney. These deleterious effects on the liver and kidney increased as the level of supplementation increased. Therefore, care should be taken when increasing Jatropha tanjorensis leaf meal in broiler chicken diets above 1.5%, and when consuming Jatropha tanjorensis leaf at higher doses because of its deleterious consequences on the histo-architecture of the kidney and liver. [ABSTRACT FROM AUTHOR]
- Published
- 2023
4. Profile of blood of weaner boars fed Tetrapleura tetraptera pod pulp meal
- Author
-
Ezea, J., primary, Ezike, J. C., additional, Nathaniel, J., additional, Ukar, I. A., additional, Oguike, M. A., additional, and Herbert, U., additional
- Published
- 2021
- Full Text
- View/download PDF
5. CHEMICAL ELEMENTS IN EGG SHELL OF A COMMERCIAL STRAIN OF DOMESTIC FOWL MANAGED IN A TROPICAL ENVIRONMENT
- Author
-
Oguike, M. A., primary
- Published
- 2021
- Full Text
- View/download PDF
6. INFLUENCE OF OVIPOSITION TIME ON SOME FUNCTIONAL PROPERTIES OF EGG SHELL OF THE DOMESTIC FOWL KEPT IN WARM HUMID TROPICS
- Author
-
OGUIKE, M. A., primary
- Published
- 2021
- Full Text
- View/download PDF
7. Effects of Spondias mombin l. On milk composition of lactating West African Dwarf (WAD) ewes
- Author
-
Oguike, M. A., primary and Udeh, M. E., additional
- Published
- 2020
- Full Text
- View/download PDF
8. Reproductive characteristics of rabbit bucks administered Panax ginseng extracts
- Author
-
Iwuji, T. C., primary, Herbert, U., additional, Oguike, M. A., additional, and Obikaonu, H. O., additional
- Published
- 2020
- Full Text
- View/download PDF
9. Effect of Melatonin and Lighting Regime on Physiological Responses and Haematological Profile of Isa Brown laying Birds.
- Author
-
Igwe, R. O., Herbert, U., Oguike, M. A., and Osakwe, I. I.
- Subjects
MELATONIN ,HEART beat ,PINEAL gland ,ANIMAL sexual behavior ,ANIMAL development - Abstract
Background: Melatonin is the main neurohormone synthesized and released by the pineal gland. It stimulates several antioxidative enzymes which increase its efficiency as an antioxidant and enhance the maturation of oocytes and the development of follicles in animals. Artificial lighting on the other hand improves bird's performance especially reproductive performance and behavior. By providing artificial light, growers can manipulate this natural cycle to their advantage and increase the egg laying. Therefore, this current study was aimed to evaluate the effect of melatonin and increased lighting on the welfare of laying birds. Methods: In November 2018 to December 2019, a total 162 sixteen weeks Isa Brown hens were used for the experiment which was grouped into 9 treatments. Melatonin and lighting at three levels (0mg, 5mg, 10mg and 12hrs, 15hrs and 18hrs) were administered orally to the birds four times weekly within a day interval for 30 weeks from 16 weeks to 46 weeks. Data on rectal temperature, respiratory rate and heart rate were collected and analysed. Blood samples were also collected and analysed for haematological parameters Result: Results showed that rectal temperature (RT), respiratory rate (RR) and heart rate (HT) were significantly (p<0.05) influenced by both melatonin and lighting. Melatonin at 5mg significantly (p<0.05) reduced the rectal temperature (40.55°C), respiratory rate (139.44bpm) and heart rate (320bpm) while lighting at 18 hours significantly (p<0.05) increased the rectal temperature, respiratory rate and heart rate due to heat stress among the parameters. The haematological profiles were influenced (p<0.05) by the administration of melatonin. Treatments levels on melatonin administration (5mg and 10mg) had increased circulating packed cell volume of 28.00% and 28.11% respectively compared to the control group which had 25.66%. The results indicates that melatonin at 5mg and 10mg improved the welfare of the birds but increased lighting beyond 12 hours compromised immunity of the birds. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
10. Increased pfmdr1 Copy Number and Sequence Polymorphisms in Plasmodium falciparum Isolates from Sudanese Malaria Patients Treated with Artemether-Lumefantrine▿
- Author
-
Gadalla, N. B., Adam, I., Elzaki, S.-E., Bashir, S., Mukhtar, I., Oguike, M., Gadalla, A., Mansour, F., Warhurst, D., El-Sayed, B. B., and Sutherland, C. J.
- Published
- 2011
- Full Text
- View/download PDF
11. Épidemiologie du scorbut dans une population precaire
- Author
-
Oguike, M., primary, Frances, P., additional, Konaté, A., additional, Chanques, G., additional, Jaber, S., additional, and Guillot, B., additional
- Published
- 2016
- Full Text
- View/download PDF
12. Clinical determinants of early parasitological response to ACTs in African patients with uncomplicated falciparum malaria: a literature review and meta-analysis of individual patient data
- Author
-
Abdulla, S, Adam, I, Adjei, G, Adjuik, M, Alemayehu, B, Allan, R, Arinaitwe, E, Ashley, E, Ba, MS, Barennes, H, Barnes, K, Bassat, Q, Baudin, E, Berens-Riha, N, Bjoerkman, A, Bompart, F, Bonnet, M, Borrmann, S, Bousema, T, Brasseur, P, Bukirwa, H, Checchi, F, Dahal, P, D'Alessandro, U, Desai, M, Dicko, A, Djimde, A, Dorsey, G, Doumbo, O, Drakeley, C, Duparc, S, Eshetu, T, Espie, E, Etard, J, Faiz, A, Falade, C, Fanello, C, Faucher, J, Faye, B, Faye, O, Filler, S, Flegg, J, Fofana, B, Fogg, C, Gadalla, N, Gaye, O, Genton, B, Gething, P, Gil, J, Gonzalez, R, Grandesso, F, Greenhouse, B, Greenwood, B, Grivoyannis, A, Guerin, P, Guthmann, J, Hamed, K, Hamour, S, Hay, S, Hodel, E, Humphreys, G, Hwang, J, Ibrahim, M, Jima, D, Jones, J, Jullien, V, Juma, E, Kachur, P, Kager, P, Kamugisha, E, Kamya, MR, Karema, C, Kayentao, K, Kiechel, J, Kironde, F, Kofoed, P, Kremsner, P, Krishna, S, Lameyre, V, Lell, B, Lima, A, Makanga, M, Malik, E, Marsh, K, Martensson, A, Massougbodji, A, Menan, H, Menard, D, Menendez, C, Mens, P, Meremikwu, M, Moreira, C, Nabasumba, C, Nambozi, M, Ndiaye, J, Ngasala, B, Nikiema, F, Nsanzabana, C, Ntoumi, F, Oguike, M, Ogutu, B, Olliaro, P, Omar, SA, Ouedraogo, J, Owusu-Agyei, S, Penali, L, Pene, M, Peshu, J, Piola, P, Plowe, C, Premji, Z, Price, R, Randrianarivelojosia, M, Rombo, L, Roper, C, Rosenthal, P, Sagara, I, Same-Ekobo, A, Sawa, P, Schallig, H, Schramm, B, Seck, A, Shekalaghe, SA, Sibley, C, Sinou, V, Sirima, S, Som, F, Sow, D, Staedke, S, Stepniewska, K, Sutherland, C, Swarthout, T, Sylla, K, Talisuna, A, Taylor, W, Temu, E, Thwing, J, Tine, R, Tinto, H, Tommasini, S, Toure, O, Ursing, J, Vaillant, M, Valentini, G, Van den Broek, I, Van Vugt, M, Ward, SA, Winstanley, P, Yavo, W, Yeka, A, Zolia, Y, Zongo, I, Based, W, Unité de Recherche sur le Paludisme [Antananarivo, Madagascar], Institut Pasteur de Madagascar, and Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)
- Subjects
Male ,Infektionsmedicin ,Antimalarial ,MESH: Africa ,law.invention ,Amodiaquine/therapeutic use ,chemistry.chemical_compound ,0302 clinical medicine ,Randomized controlled trial ,[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases ,law ,030212 general & internal medicine ,Artemether ,Prospective Studies ,Malaria, Falciparum ,Prospective cohort study ,MESH: Plasmodium falciparum ,Medicine(all) ,MESH: Middle Aged ,MESH: Malaria, Falciparum ,Malaria, Falciparum/drug therapy ,General Medicine ,Middle Aged ,MESH: Infant ,Artemisinins ,3. Good health ,Drug Combinations ,Meta-analysis ,parasite ,Quinolines ,Drug Therapy, Combination ,Artemisinin based Combination Therapy (ACT) ,MESH: Quinolines ,medicine.drug ,Falciparum ,Infectious Medicine ,medicine.medical_specialty ,030231 tropical medicine ,Plasmodium falciparum ,ARTEMISININ-RESISTANT MALARIA PLASMODIUM-FALCIPARUM PARASITE CLEARANCE ARTEMETHER-LUMEFANTRINE COMBINATION THERAPY IN-VIVO EFFICACY ARTESUNATE CHILDREN PHARMACOKINETICS ,Quinolines/administration & dosage ,African patients ,03 medical and health sciences ,Antimalarials ,Internal medicine ,MESH: Artemisinins ,parasitic diseases ,Artemisinin combination therapy ,medicine ,Humans ,MESH: Africa South of the Sahara ,Falciparum malaria ,Risk factor ,MESH: Amodiaquine ,Africa South of the Sahara ,Parasite clearance ,MESH: Drug Combinations ,MESH: Humans ,business.industry ,Amodiaquine ,Infant ,Odds ratio ,MESH: Antimalarials ,MESH: Male ,MESH: Prospective Studies ,Surgery ,Malaria ,Clinical trial ,Artemisinins/administration & dosage ,MESH: Drug Therapy, Combination ,chemistry ,Artesunate ,Africa ,Commentary ,Antimalarials/administration & dosage ,business - Abstract
WWARN Artemisinin based Combination Therapy (ACT) Africa Baseline Study Group; International audience; Background: Artemisinin-resistant Plasmodium falciparum has emerged in the Greater Mekong sub-region and poses a major global public health threat. Slow parasite clearance is a key clinical manifestation of reduced susceptibility to artemisinin. This study was designed to establish the baseline values for clearance in patients from Sub-Saharan African countries with uncomplicated malaria treated with artemisinin-based combination therapies (ACTs). Methods: A literature review in PubMed was conducted in March 2013 to identify all prospective clinical trials (uncontrolled trials, controlled trials and randomized controlled trials), including ACTs conducted in Sub-Saharan Africa, between 1960 and 2012. Individual patient data from these studies were shared with the WorldWide Antimalarial Resistance Network (WWARN) and pooled using an a priori statistical analytical plan. Factors affecting early parasitological response were investigated using logistic regression with study sites fitted as a random effect. The risk of bias in included studies was evaluated based on study design, methodology and missing data. Results: In total, 29,493 patients from 84 clinical trials were included in the analysis, treated with artemether-lumefantrine (n = 13,664), artesunate-amodiaquine (n = 11,337) and dihydroartemisinin-piperaquine (n = 4,492). The overall parasite clearance rate was rapid. The parasite positivity rate (PPR) decreased from 59.7 % (95 % CI: 54.5–64.9) on day 1 to 6.7 % (95 % CI: 4.8–8.7) on day 2 and 0.9 % (95 % CI: 0.5–1.2) on day 3. The 95th percentile of observed day 3 PPR was 5.3 %. Independent risk factors predictive of day 3 positivity were: high baseline parasitaemia (adjusted odds ratio (AOR) = 1.16 (95 % CI: 1.08–1.25); per 2-fold increase in parasite density, P 37.5 °C) (AOR = 1.50 (95 % CI: 1.06–2.13), P = 0.022); severe anaemia (AOR = 2.04 (95 % CI: 1.21–3.44), P = 0.008); areas of low/moderate transmission setting (AOR = 2.71 (95 % CI: 1.38–5.36), P = 0.004); and treatment with the loose formulation of artesunate-amodiaquine (AOR = 2.27 (95 % CI: 1.14–4.51), P = 0.020, compared to dihydroartemisinin-piperaquine). Conclusions: The three ACTs assessed in this analysis continue to achieve rapid early parasitological clearance across the sites assessed in Sub-Saharan Africa. A threshold of 5 % day 3 parasite positivity from a minimum sample size of 50 patients provides a more sensitive benchmark in Sub-Saharan Africa compared to the current recommended threshold of 10 % to trigger further investigation of artemisinin susceptibility.
- Published
- 2015
13. The effect of dose on the antimalarial efficacy of artemether-lumefantrine: a systematic review and pooled analysis of individual patient data
- Author
-
Anstey, NM, Price, RN, Davis, TME, Karunajeewa, HA, Mueller, I, D'Alessandro, U, Massougbodji, A, Nikiema, F, Ouedraogo, JB, Tinto, H, Zongo, I, Same-Ekobo, A, Kone, M, Menan, H, Toure, AO, Yavo, W, Kofoed, PE, Alemayehu, BH, Jima, D, Baudin, E, Espie, E, Nabasumba, C, Pinoges, L, Schramm, B, Cot, M, Deloron, P, Faucher, JF, Guthmann, JP, Lell, B, Borrmann, S, Adjei, GO, Ursing, J, Tjitra, E, Marsh, K, Peshu, J, Juma, E, Ogutu, BR, Omar, SA, Sawa, P, Talisuna, AO, Khanthavong, M, Mayxay, M, Newton, PN, Piola, P, Djimde, AA, Doumbo, OK, Fofana, B, Sagara, I, Bassat, Q, Gonzalez, R, Menendez, C, Smithuis, F, Bousema, T, Kager, PA, Mens, PF, Schallig, HDFH, van Den Broek, I, van Vugt, M, Ibrahim, ML, Falade, CO, Meremikwu, M, Gil, JP, Karema, C, Ba, MS, Faye, B, Faye, O, Gaye, O, Ndiaye, JL, Pene, M, Sow, D, Sylla, K, Tine, RCK, Penali, LK, Barnes, KI, Workman, LJ, Lima, A, Adam, I, Gadalla, NB, Malik, EFM, Bjorkman, A, Martensson, A, Ngasala, BE, Rombo, L, Aliu, P, Duparc, S, Filler, S, Genton, B, Hodel, EM, Olliaro, P, Abdulla, S, Kamugisha, E, Premji, Z, Shekalaghe, SA, Ashley, EA, Carrara, VI, McGready, R, Nosten, F, Faiz, AM, Lee, SJ, White, NJ, Dondorp, AM, Smith, JJ, Tarning, J, Achan, J, Bukirwa, H, Yeka, A, Arinaitwe, E, Staedke, SG, Kamya, MR, Kironde, F, Drakeley, CJ, Oguike, M, Sutherland, CJ, Checchi, F, Dahal, P, Flegg, JA, Guerin, PJ, Moreira, C, Nsanzabana, C, Sibley, CH, Stepniewska, K, Gething, PW, Hay, SI, Greenwood, B, Ward, SA, Winstanley, PA, Dorsey, G, Greenhouse, B, Rosenthal, PJ, Grivoyannis, A, Hamed, K, Hwang, J, Kachur, PS, and Nambozi, M
- Published
- 2015
14. Assessment of the reproductive impact of Ethiopian pepper (Xylopia aethiopica) on rabbit bucks.
- Author
-
Ansa, A. A., Mbaleto, C. S., and Oguike, M. A.
- Subjects
XYLOPIA ,SPERM motility ,SEMEN - Abstract
Copyright of Archivos de Zootecnia is the property of Archivos de Zootecnia and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2017
- Full Text
- View/download PDF
15. Alternatively spliced transcripts and novel pseudogenes of the Plasmodium falciparum resistance-associated locus pfcrt detected in East African malaria patients
- Author
-
Gadalla, N. B., primary, Malmberg, M., additional, Adam, I., additional, Oguike, M. C., additional, Beshir, K., additional, Elzaki, S.-E., additional, Mukhtar, I., additional, Gadalla, A. A., additional, Warhurst, D. C., additional, Ngasala, B., additional, Martensson, A., additional, El-Sayed, B. B., additional, Gil, J. P., additional, and Sutherland, C. J., additional
- Published
- 2014
- Full Text
- View/download PDF
16. Pigeon Pea [Cajanus cajan (L.) Millsp.] Seed Meal in Layer Diets: 3. Effect of Higher Inclusion Level and Prolonged Feeding of Raw or Processed Pigeon Pea Seed Meal Diets from Pullet Chick Stage on the Laying Performance of Pullets
- Author
-
.U. Amaefu, K, primary, A. Oguike, M., additional, O. Ironkwe, M., additional, and C. Obioha, F., additional
- Published
- 2007
- Full Text
- View/download PDF
17. COMPARISON OF THE SUPPLEMENTAL EFFECTS OF ROXAZYME-G ENZYME IN PALM KERNEL MEAL AND BREWERS DRIED GRAIN BASED DIETS FED TO MALE TURKEY POULTS
- Author
-
OJEWOLA, G. S, primary, OGUIKE,, M. A., additional, AKOMAS, S. C, additional, LIKITA, T., additional, ONYIRO, O. M, additional, and WOKOCHA, C., additional
- Published
- 2004
- Full Text
- View/download PDF
18. Seasonal Variation in the Physical Characteristics of Egg Shell of Domestic Chicken Kept in Warm Humid Tropics
- Author
-
Oguike, M. A., primary
- Published
- 1994
- Full Text
- View/download PDF
19. Subpatent Plasmodium with mutant pfmdr1, pfcrt, and pvmdr1 alleles from endemic provinces in Mindanao, the Philippines: implications for local malaria elimination.
- Author
-
Dacuma MGB, Dimalibot JC, Baril JA, Allian F, Bahidjan DK, Mori V, Asri S, Yadao F, Notario W, Bona E, Jr JB, Oguike M, Drakeley C, Hallett R, and Sutherland CJ
- Subjects
- Alleles, Humans, Membrane Transport Proteins genetics, Membrane Transport Proteins therapeutic use, Multidrug Resistance-Associated Proteins genetics, Multidrug Resistance-Associated Proteins therapeutic use, Philippines, Plasmodium falciparum genetics, Protozoan Proteins genetics, Protozoan Proteins metabolism, Protozoan Proteins therapeutic use, Antimalarials therapeutic use, Malaria drug therapy, Malaria epidemiology, Malaria prevention & control, Malaria, Falciparum drug therapy, Plasmodium
- Abstract
Objectives: This study was performed to identify and characterize circulating Plasmodium species in three provinces of Mindanao approaching malaria elimination., Methods: Rapid diagnostic tests (RDT), microscopic examination, and PCR were used to detect malaria parasites. PCR-positive isolates were genotyped for polymorphisms in loci of interest., Results: A total of 2639 participants were surveyed in Mindanao between 2010 and 2013. Malaria prevalence by PCR was 3.8% (95% confidence interval (CI): 2.7-5.2%) in Sarangani, 10% (95% CI: 7.7-12.7%) in South Cotabato, and 4.2% (95% CI: 3.2-5.6%) in Tawi-Tawi. P. falciparum and P. vivax were identified in all three provinces, and there was one case of P. malariae in South Cotabato. RDT was inferior to PCR for detecting asymptomatic P. falciparum and P. vivax. In Tawi-Tawi, microscopy failed to identify 46 PCR-positive malaria infections. The presence of pfcrt haplotypes CVMNK, CVIET, and SMNT (codons 72-76), pfmdr1 haplotype NFSND (codons 86, 184, 1034, 1042, 1246), and pvmdr1 haplotype NFL (codons 91, 976, 1076) was confirmed in Mindanao., Conclusions: Asymptomatic Plasmodium infections persisted in local communities between 2010 and 2013. PCR successfully identified subpatent malaria infections, and can better characterize malaria epidemiology in communities seeking malaria control and elimination at the local level., Competing Interests: Declaration of Competing Interest None., (Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
20. Plasmodium malariae and Plasmodium ovale infections and their association with common red blood cell polymorphisms in a highly endemic area of Uganda.
- Author
-
Subissi L, Kanoi BN, Balikagala B, Egwang TG, Oguike M, Verra F, Proietti C, Bousema T, Drakeley CJ, and Sepúlveda N
- Subjects
- Adolescent, Child, Child, Preschool, Cross-Sectional Studies, Female, Health Surveys, Humans, Infant, Malaria, Falciparum parasitology, Male, Polymerase Chain Reaction, Uganda epidemiology, Young Adult, Erythrocytes microbiology, Erythrocytes, Abnormal microbiology, Malaria, Falciparum epidemiology, Plasmodium falciparum isolation & purification, Plasmodium ovale isolation & purification, Polymorphism, Genetic
- Abstract
Background: Plasmodium ovale and Plasmodium malariae infections are scarcely studied in sub-Saharan Africa, where the Plasmodium falciparum species predominates. The objective of this study is to investigate the prevalence of P. ovale and P. malariae infections and their relationship with common red blood cell polymorphisms in a cohort of 509 individuals from Uganda., Methods: Three cross-sectional surveys were conducted in individuals of 1-10 and >20 y of age from the Apac district at baseline and 6 and 16 weeks after drug treatment. Malaria infections were assessed by polymerase chain reaction and genotyping was performed for the sickle-cell allele, α-thalassaemia and glucose-6-phosphate dehydrogenase., Results: At baseline, the prevalence of infection was 7.5%, 12.6% and 57.4% for P. ovale, P. malariae and P. falciparum species, respectively. Co-infections were present in 14.1% of individuals, all including P. falciparum parasites. In children 1-5 y of age, the prevalence of P. ovale mono-infections increased significantly from 1.7% to 7.3% over time (p=0.004) while the prevalence of P. malariae and P. falciparum infections declined significantly during this study. After adjusting for confounding and multiple testing, only α-thalassaemia had a statistically significant increase in the odds of P. falciparum infections (odds ratio 1.93 [95% confidence interval 1.26 to 2.94])., Conclusions: Common red blood cell polymorphisms do not show strong effects on mild Plasmodium infections in this Ugandan population. To understand the extent of this result, similar studies should be carried out in other populations using larger cohorts., (© The Author(s) 2019. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2019
- Full Text
- View/download PDF
21. Point-of-care creatinine testing in patients receiving contrast-enhanced computed tomography scan.
- Author
-
Bargnoux AS, Beaufils O, Oguike M, Lopasso A, Dupuy AM, Sebbane M, Badiou S, Fesler P, and Cristol JP
- Subjects
- Contrast Media, Emergency Service, Hospital, Glomerular Filtration Rate, Humans, Kidney Diseases diagnosis, Kidney Function Tests methods, Time Factors, Tomography, X-Ray Computed adverse effects, Tomography, X-Ray Computed standards, Blood Gas Analysis instrumentation, Creatinine blood, Point-of-Care Systems standards
- Abstract
Background: The aim of this study was to evaluate the creatinine assay on the ABL800 FLEX© blood gas analyzer for the screening of pre-existing renal impairment before radiographic contrast administration in the emergency department (ED), by comparing it with standard practice using central laboratory blood testing., Methods: The evaluation comprised two elements. The first, conducted in the central laboratory, focused on the analytical performance of the ABL800 creatinine assay. This included assessment of imprecision and accuracy by comparison with central laboratory standard creatinine assay. We also compared ABL 800 estimated glomerular filtration rate (eGFR) and
99m Tc-DTPA measured GFR (mGFR). The second part, conducted in ED sought to determine the impact that implementation of the creatinine at the point-of-care (POC) has on the timeframe in which ED patients are submitted for computed tomography scan (CT)., Results: The ABL800 enzymatic creatinine assay met the National Kidney Disease Education Program acceptance criteria for imprecision and showed good agreement with the isotope dilution mass spectrometry-traceable Roche enzymatic assay used in the central laboratory. Furthermore, ABL800 eGFR was in total agreement with mGFR by a reference method. The implementation of POC testing creatinine in the ED significantly reduced patient waiting times for contrast enhanced CT (1.73[0.75-3.01] vs 2.57 [1.53-3.48] hours, for period with and without ABL800 respectively, p=0.04)., Conclusion: The ABL800 assay is comparable with central laboratory reference method in terms of analytical performance and superior in terms of turnaround time. Implementation of creatinine at POC reduces delay results, potentially allowing ED clinical staff to make more rapid clinical decisions and reduce patient waiting time., (Copyright © 2017 Elsevier B.V. All rights reserved.)- Published
- 2018
- Full Text
- View/download PDF
22. Assessment of Markers of Antimalarial Drug Resistance in Plasmodium falciparum Isolates from Pregnant Women in Lagos, Nigeria.
- Author
-
Agomo CO, Oyibo WA, Sutherland C, Hallet R, and Oguike M
- Subjects
- Adult, Female, Humans, Nigeria, Pregnancy, Pregnant Women, Young Adult, Antimalarials therapeutic use, Drug Resistance genetics, Malaria, Falciparum drug therapy, Membrane Transport Proteins genetics, Plasmodium falciparum isolation & purification, Pregnancy Complications drug therapy, Protozoan Proteins genetics, Quinolines therapeutic use
- Abstract
Background: The use of antimalarial drugs for prevention and treatment is a major strategy in the prevention of malaria in pregnancy. Although sulphadoxine-pyrimethamine (SP) is currently recommended for intermittent preventive treatment of malaria during pregnancy in Nigeria, previously used drugs for prophylaxis such as chloroquine (CQ) and pyrimethamine are accessible as they are purchased over the counter. This study describes the markers of absence or presence of resistance to quinoline (Pfcrt and Pfmdr 1) and type 1 antifolate antimalarial medicines (Pfdhfr)., Methods: Plasmodium falciparum-positive dried blood spots from pregnant women attending antenatal clinics for the first time during current pregnancy were investigated for the presence of mutations at codons 72-76 of Plasmodium falciparum chloroquine resistance transporter (Pfcrt) gene by real time polymerase chain reaction (PCR) using haplotype-specific probes. PCR followed by sequence analysis was used to identify mutations at codons 86, 184, 1034, 1042 and 1246 of P. falciparum multi-drug resistance-1 (Pfmdr1) gene; and codons 16, 50, 51, 59, 108, 140 and 164 of Pfdhfr gene., Results: Two haplotypes of Pfcrt (n = 54) were observed: CVMNK 13(24.2%) and CVIET 41 (75.9%) of the samples. The SVMNT haplotype was absent in this population. The Pfmdr1 (n = 28) haplotypes were NYSND 15(53.6%), YYSND 5(17.9%), NFSND 6(21.4%) and YFSND 2(7.1%). The Pfdhfr (n = 15) were ACNCSVI 4(26.7%), and ACICNSVI 1(6.7%) and ACIRNVI 10 (66.7%). The rate of occurrence of Pfcrt 76T, Pfdhfr108N, Pfmdr186Y and 184F were 75.9%, 73.3%, 25% and 28.1% respectively. The Pfmdr1 86Y was associated with low parasitaemia (median = 71 parasites/μl, P = 0.024) while Pfcrt 76T was associated with young maternal age (mean 24.1 ± 4.5 years; P = 0.006). The median parasitaemia were similar (P>0.05) in wild and mutant strains of Pfcrt 76, Pfmdr1 184 and Pfdhfr 108. There was no association between gravidity or gestational age of the women and presence of mutations in the Pfcrt, Pfmdr1 or Pfdhfr genes (P>0.05)., Conclusion: Markers of resistance to chloroquine and pyrimethamine were high, whereas cycloguanil-resistance marker was not present in the studied population. The low level of mutations in the Pfmdr1gene indicates likely efficacy of amodiaquine against malaria in pregnancy.
- Published
- 2016
- Full Text
- View/download PDF
23. Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine.
- Author
-
Venkatesan M, Gadalla NB, Stepniewska K, Dahal P, Nsanzabana C, Moriera C, Price RN, Mårtensson A, Rosenthal PJ, Dorsey G, Sutherland CJ, Guérin P, Davis TME, Ménard D, Adam I, Ademowo G, Arze C, Baliraine FN, Berens-Riha N, Björkman A, Borrmann S, Checchi F, Desai M, Dhorda M, Djimdé AA, El-Sayed BB, Eshetu T, Eyase F, Falade C, Faucher JF, Fröberg G, Grivoyannis A, Hamour S, Houzé S, Johnson J, Kamugisha E, Kariuki S, Kiechel JR, Kironde F, Kofoed PE, LeBras J, Malmberg M, Mwai L, Ngasala B, Nosten F, Nsobya SL, Nzila A, Oguike M, Otienoburu SD, Ogutu B, Ouédraogo JB, Piola P, Rombo L, Schramm B, Somé AF, Thwing J, Ursing J, Wong RPM, Zeynudin A, Zongo I, Plowe CV, Sibley CH, and Asaq Molecular Marker Study Group
- Subjects
- Amino Acid Substitution, Amodiaquine therapeutic use, Antimalarials pharmacology, Artemether, Artemisinins therapeutic use, Child, Child, Preschool, Chloroquine pharmacology, Datasets as Topic, Drug Combinations, Drug Resistance genetics, Drug Therapy, Combination, Ethanolamines therapeutic use, Fluorenes therapeutic use, Genetic Markers genetics, Genotype, Humans, Infant, Kaplan-Meier Estimate, Lumefantrine, Malaria, Falciparum drug therapy, Plasmodium falciparum drug effects, Risk Factors, Antimalarials therapeutic use, Malaria, Falciparum parasitology, Membrane Transport Proteins genetics, Multidrug Resistance-Associated Proteins genetics, Plasmodium falciparum genetics, Polymorphism, Genetic, Protozoan Proteins genetics
- Abstract
Adequate clinical and parasitologic cure by artemisinin combination therapies relies on the artemisinin component and the partner drug. Polymorphisms in the Plasmodium falciparum chloroquine resistance transporter (pfcrt) and P. falciparum multidrug resistance 1 (pfmdr1) genes are associated with decreased sensitivity to amodiaquine and lumefantrine, but effects of these polymorphisms on therapeutic responses to artesunate-amodiaquine (ASAQ) and artemether-lumefantrine (AL) have not been clearly defined. Individual patient data from 31 clinical trials were harmonized and pooled by using standardized methods from the WorldWide Antimalarial Resistance Network. Data for more than 7,000 patients were analyzed to assess relationships between parasite polymorphisms in pfcrt and pfmdr1 and clinically relevant outcomes after treatment with AL or ASAQ. Presence of the pfmdr1 gene N86 (adjusted hazards ratio = 4.74, 95% confidence interval = 2.29 - 9.78, P < 0.001) and increased pfmdr1 copy number (adjusted hazards ratio = 6.52, 95% confidence interval = 2.36-17.97, P < 0.001 : were significant independent risk factors for recrudescence in patients treated with AL. AL and ASAQ exerted opposing selective effects on single-nucleotide polymorphisms in pfcrt and pfmdr1. Monitoring selection and responding to emerging signs of drug resistance are critical tools for preserving efficacy of artemisinin combination therapies; determination of the prevalence of at least pfcrt K76T and pfmdr1 N86Y should now be routine., (© The American Society of Tropical Medicine and Hygiene.)
- Published
- 2014
- Full Text
- View/download PDF
24. Evaluation of the comparative efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine and artesunate-amodiaquine-chlorpheniramine (Artemoclo™) for the treatment of acute uncomplicated malaria in Nigerian children.
- Author
-
Falade CO, Dada-Adegbola HO, Ogunkunle OO, Oguike MC, Nash O, and Ademowo OG
- Subjects
- Adolescent, Amodiaquine administration & dosage, Antimalarials administration & dosage, Artemether, Artemisinins administration & dosage, Child, Child, Preschool, Chlorpheniramine administration & dosage, Drug Combinations, Drug Therapy, Combination, Ethanolamines administration & dosage, Female, Fluorenes administration & dosage, Genome, Protozoan, Humans, Infant, Lumefantrine, Male, Nigeria, Polymerase Chain Reaction, Amodiaquine therapeutic use, Antimalarials therapeutic use, Artemisinins therapeutic use, Chlorpheniramine therapeutic use, Ethanolamines therapeutic use, Fluorenes therapeutic use, Malaria drug therapy
- Abstract
Objective: To evaluate the comparative efficacy and safety of artemether-lumefantrine (AL), artesunate-amodiaquine (ASAQ) and artesunate-amodiaquine-chlorpheniramine (AQC) for the treatment of acute uncomplicated malaria among Southwest Nigerian children., Subjects and Methods: One hundred and sixty children aged 6 months to 14 years with acute uncomplicated malaria were randomized to AL (n = 53), ASAQ (n = 53), or AQC (n = 54). Enrollees were seen daily on days 0-3 and then on days 7, 14, 21, 28 and 42 for clinical and parasitological evaluations. Paired samples of genomic DNA at enrolment and at the time of recurrent parasitaemia were genotyped using nested PCR to distinguish between reinfection and recrudescence. Detailed haematological and biochemical evaluations were carried out in a subset of enrollees on days 0, 7 and 28 as part of a safety evaluation., Results: Of the 160 children, 144 (90%) completed the study. The mean fever clearance times and parasite clearance times for AL, ASAQ and AQC were comparable (p = 0.94 and p = 0.122, respectively). On day 14, the adequate clinical and parasitological response (ACPR) for AL and AQC was 100% and for ASAQ it was 90% (p = 0.39). The PCR-uncorrected results on days 28 and 42 and the ACPR-corrected results on day 42 were similar for all drugs (p = 0.62 and p = 0.56, respectively). AQC resulted in the best parasite clearance and haematological recovery on day 2 (p = 0.022 and p = 0.018, respectively). Biochemical parameters were not adversely affected by the three artemisinin-based combination therapies (ACTs) and these were well tolerated., Conclusion: The three ACTs were efficacious and safe, but AQC resulted in a better haematological recovery on day 2 and higher cure rates throughout the study period., (© 2014 S. Karger AG, Basel.)
- Published
- 2014
- Full Text
- View/download PDF
25. Two nonrecombining sympatric forms of the human malaria parasite Plasmodium ovale occur globally.
- Author
-
Sutherland CJ, Tanomsing N, Nolder D, Oguike M, Jennison C, Pukrittayakamee S, Dolecek C, Hien TT, do Rosário VE, Arez AP, Pinto J, Michon P, Escalante AA, Nosten F, Burke M, Lee R, Blaze M, Otto TD, Barnwell JW, Pain A, Williams J, White NJ, Day NP, Snounou G, Lockhart PJ, Chiodini PL, Imwong M, and Polley SD
- Subjects
- Animals, Genetic Variation, Genotype, Global Health, Humans, Malaria epidemiology, Phylogeny, Plasmodium ovale classification, RNA, Ribosomal genetics, Malaria parasitology, Plasmodium ovale genetics
- Abstract
Background: Malaria in humans is caused by apicomplexan parasites belonging to 5 species of the genus Plasmodium. Infections with Plasmodium ovale are widely distributed but rarely investigated, and the resulting burden of disease is not known. Dimorphism in defined genes has led to P. ovale parasites being divided into classic and variant types. We hypothesized that these dimorphs represent distinct parasite species., Methods: Multilocus sequence analysis of 6 genetic characters was carried out among 55 isolates from 12 African and 3 Asia-Pacific countries., Results: Each genetic character displayed complete dimorphism and segregated perfectly between the 2 types. Both types were identified in samples from Ghana, Nigeria, São Tomé, Sierra Leone, and Uganda and have been described previously in Myanmar. Splitting of the 2 lineages is estimated to have occurred between 1.0 and 3.5 million years ago in hominid hosts., Conclusions: We propose that P. ovale comprises 2 nonrecombining species that are sympatric in Africa and Asia. We speculate on possible scenarios that could have led to this speciation. Furthermore, the relatively high frequency of imported cases of symptomatic P. ovale infection in the United Kingdom suggests that the morbidity caused by ovale malaria has been underestimated.
- Published
- 2010
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.